Maria C. Freire
CIK: 0001547999
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 9, 2026BIIB
BIOGEN INC.
Award(A)Direct2K shares- - May 27, 2026EXEL
EXELIXIS, INC.
Award(A)Direct8.4K shares- - May 7, 2026EXEL
EXELIXIS, INC.
Exercise(M)Direct20.6K shares at avg. $19.77$408K - May 7, 2026EXEL
EXELIXIS, INC.
Sale(S)Direct20.6K shares at avg. $46.00$949K - Jan 15, 2026ARE
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Award(A)Direct3.5K shares- - Jun 17, 2025BIIB
BIOGEN INC.
Award(A)Direct2.4K shares- - May 29, 2025EXEL
EXELIXIS, INC.
Award(A)Direct9.8K shares- - Feb 14, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct15.9K shares at avg. $20.50$325K - Feb 14, 2025EXEL
EXELIXIS, INC.
Sale(S)Direct44.1K shares at avg. $34.94$1.5M - Feb 14, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct28.2K shares at avg. $22.10$624K - Jan 15, 2025ARE
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Award(A)Direct2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  BIIB BIOGEN INC. | Award(A) | 2,005 | - | $0 | Direct |
| May 27, 2026 |  EXEL EXELIXIS, INC. | Award(A) | 8,367 | - | $0 | Direct |
| May 7, 2026 | EXEL EXELIXIS, INC. | Exercise(M) | 20,634 | $19.77 | $407,934 | Direct |
| May 7, 2026 | EXEL EXELIXIS, INC. | Sale(S) | 20,634 | $46.00 | $949,164 | Direct |
| Jan 15, 2026 |  ARE ALEXANDRIA REAL ESTATE EQUITIES, INC. | Award(A) | 3,493 | - | $0 | Direct |
| Jun 17, 2025 | BIIB BIOGEN INC. | Award(A) | 2,370 | - | - | Direct |
| May 29, 2025 | EXEL EXELIXIS, INC. | Award(A) | 9,812 | - | - | Direct |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 15,874 | $20.50 | $325,417 | Direct |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | Sale(S) | 44,114 | $34.94 | $1,541,343 | Direct |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 28,240 | $22.10 | $624,104 | Direct |
| Jan 15, 2025 | ARE ALEXANDRIA REAL ESTATE EQUITIES, INC. | Award(A) | 2,032 | - | $0 | Direct |
1-11 of 11 transactions
About Freire Maria C
Freire Maria C (SEC CIK 0001547999) files insider reports with the SEC as Director of BIOGEN INC. (BIIB), Director of EXELIXIS, INC. (EXEL) and Director of ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE).
Signal8 holds 8 ownership filings by Freire Maria C, all Form 4s, filed between Jan 17, 2025 and Jun 11, 2026. Those filings report 11 transactions, from Jan 15, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Freire Maria C's filings is in CAMBRIDGE, MA.
Recent filings by Freire Maria C
- Jun 9, 2026: Grant or award of BIIB shares (Form 4, code A).
- May 27, 2026: Grant or award of EXEL shares (Form 4, code A).
- May 7, 2026: Option exercise of EXEL shares (Form 4, code M).
- May 7, 2026: Open-market sale of EXEL shares (Form 4, code S).
- Jan 15, 2026: Grant or award of ARE shares (Form 4, code A).
Other insiders filing for BIOGEN INC. (BIIB)
- Grogan Jane, Head of Research
- Godbout Sean, Chief Accounting Officer
- Parini Michael, Chief Legal Officer
- Minor Lloyd, Director
- HAWKINS WILLIAM A, Director
- SHERWIN STEPHEN A, Director